Currently Viewing:
Association of Community Cancer Centers Annual Meeting
Currently Reading
The Price of Innovation When Improving Cancer Care Delivery
March 15, 2018
Changing Trends in Oncology Practice: Value-Based Care and an Empowered Patient
March 15, 2018
Why Tom Gallo Wants to Address Burnout During His Year as ACCC President
March 15, 2018
Roger Holzberg Discusses Integrating Technology Into Healthcare
March 16, 2018
Investing in the Vital Role of a Cancer Care Coordinator
March 16, 2018
Barbara Tofani: The United States Underestimated the Need for Care Coordination
March 16, 2018
Technology Integration in Community Oncology Practice: Building the Future
March 16, 2018
Experts Emphasize the Value of Cancer Care Integration at ACCC Meeting
March 21, 2018
Tom Gallo: Burnout Needs to Be Addressed for All Members of the Care Team
April 03, 2018
Tom Gallo Discusses How Burnout Is Increasing and the Role of Technology
April 06, 2018
Dr Kathleen Blake Discusses the Impact Healthcare Industry Changes Have on Burnout
April 23, 2018
Dr Mark Soberman on the Next Generation Multidisciplinary Cancer Care Team
April 27, 2018
Dr Mark Soberman on the Importance of Communication Among Integrated Care Teams
May 01, 2018
Dr Charles Saunders Outlines the Increasing Importance of Technology in Practices
May 03, 2018
Barbara Tofani: The Old Ways of Coordinating Care Are Gone
May 07, 2018
Dr James Hamrick: Community Practices Help Increase Diversity in Clinical Trials
May 08, 2018
Dr Kathleen Blake Highlights Telltale Signs of Burnout
May 10, 2018
Dr Yousuf Zafar Discusses the Burden of Financial Toxicity and Trends Over Time
May 14, 2018
Thomas Asfeldt Highlights 3 Key Challenges to Creating Integrated Cancer Care Teams
May 15, 2018
Pamela Tobias Discusses Pulling Data from EHRs to Improve Processes
May 15, 2018
Dr Mark Soberman Discusses Integrated Care Teams in Oncology
May 16, 2018
Dr Charles Saunders Highlights Data Collection Challenges
May 18, 2018
Dr Kathleen Blake Outlines How Burnout Affects Specialties Differently
May 21, 2018
Barbara Tofani Outlines Best Practices and Mistakes of Care Coordination
May 22, 2018

The Price of Innovation When Improving Cancer Care Delivery

Surabhi Dangi-Garimella, PhD
At the Association of Community Cancer Center’s 44th Annual Meeting & Cancer Center Business Summit, March 14-16, 2018, in Washington, DC, payer and physician representatives shared the stage with the president of a cancer foundation that is striving to break the barriers that prevent easy healthcare information exchange and access to cancer care.
Levine then asked the panelists what they would like to change about the system and the steps they would take to implement changes.

“Transparency of the system,” McAneny said. “We rank 19th among industrialized nations with respect to the transparency within our healthcare system,” she said, adding that the stream of middlemen between the patient and the provider add significant costs that are not very visible.

She reiterated the importance of SDH on improving the overall health of our care system.

Simon took a very stance. “Abolish tenure,” he said. In his belief, faculty at academic institutions apply for grants, which are then used to conduct research. However, 40% of the time, companies that spinoff from these laboratories are not able to reproduce some of the results that were originally published, according to Simon. This statement underscored the vicious cycle that exists between grant-writing, faculty tenure, and the business of science and health.

For Shah, it’s the mantra of patient-first. “We have a long-way to go to provide patients with the tools for enhancing transparency and making them aware of their choices and to make them engaged,” he said.
From the payer perspective, investment for innovation is important. “I like Medical Advantage,” Beveridge said, “because it’s a stable payment platform, our patients stay with us for about 8 years, and its risk-adjusted. It also helps you figure what is important for patients: food insecurity, transportation etc.”

How about the cost of innovation? “What happens if innovation makes our health system costlier, despite the promise of improved outcomes?” Levine asked.

Beveridge clarified that payers are willing to pay if they see a significant improvement in care delivery or treatment outcomes. “Remember: payers represent employer groups or the government when they make decisions on what they are willing to pay [for a drug or treatment],” he said. He raised concerns with the inefficiencies of the existing system, including treatments that are not of high-quality. “There’s a lot of waste, and unless we have the cost-benefit information, we can’t do much, Beveridge added.

Simon presented a different viewpoint on how better health has a positive impact on the economy because the patient [read workforce] is now doing better. “In healthcare, we do not think of health as an asset… why is it treated as a cost?” he asked.

Insurance companies do not know their liabilities or their patients a year in advance. If insurance companies cannot protect their risk in the healthcare world, that’s tough.

“Our focus has to be what we can do for the individual patient. Our current track is healthcare, which does not translate into health,” said McAneny. “We need to look responsibly at how do we deliver new treatments to patients without breaking the bank. Can we afford to spend 1.5- to 3-times for the same service and outcomes in a hospital vs physician setting.”

Levine finally asked the panelists’ perspectives on innovation: How do they impact practicing physicians? What will the doctors experience over the next few years?

With CMMI, physicians feel they have an opportunity, McAneny said. “One thing that the Oncology Care Model )OCM) has created is that CMS is not an adversary, rather a partner. AMA is working on helping physicians across the country to look at APMs, to help physicians from different specialties and communities to submit ideas,” she said, adding that payers have realized that 1-size fits all will not serve as a good model.

“We need to come up with a way to improve the quality of the affordable care that we provide, but we cannot afford to destroy the infrastructure that provides this care, in the process,” McAneny said, addressing the administrative and financial burden that some of the reporting requirements demand. The panelists agreed that physicians cannot be put at risk for things they cannot control.

Beveridge emphasized the need for alignment. “We need to understand data flow to help empower physicians. With the movement from volume to value, there’s a change in relations among stakeholders,” which he said is evident in primary care, where there are aligned interests, but has yet to be fully embraced in oncology. “Improving health, improving their functionality, and aligning it with payers is key,” Beveridge said.



 

Related Articles

Validating Electronic Cancer Quality Measures at Veterans Health Administration
Dr Toby Campbell: High-Quality Cancer Care Includes Palliative Care
Employers Express Their Concerns With Cancer Care at the COA Summit
Changing Trends in Oncology Practice: Value-Based Care and an Empowered Patient
Why Tom Gallo Wants to Address Burnout During His Year as ACCC President
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up